Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. - Wikidata - awgldk - TriplyDB

Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors.

Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors.

http://www.wikidata.org/entity/Q36829303

about

Sulfonylurea receptor 1 in central nervous system injury: a focused review Blood Pressure in Acute Ischemic Stroke Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications Vascular protection to increase the safety of tissue plasminogen activator for stroke Predicting a post-thrombolysis intracerebral hemorrhage: a systematic review Characterization of ultrasound propagation through ex-vivo human temporal bone Development of a computerised decision aid for thrombolysis in acute stroke care.Genome response to tissue plasminogen activator in experimental ischemic stroke Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes.The risk of intravenous thrombolysis-induced intracranial hemorrhage in Taiwanese patients with unruptured intracranial aneurysm.Stroke management.Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients?Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients.A review of decision support, risk communication and patient information tools for thrombolytic treatment in acute stroke: lessons for tool developers Risk assessment of hemorrhagic transformation of acute middle cerebral artery stroke using multimodal CT Admission CT perfusion is an independent predictor of hemorrhagic transformation in acute stroke with similar accuracy to DWI.Permeability Parameters Measured with Dynamic Contrast-Enhanced MRI: Correlation with the Extravasation of Evans Blue in a Rat Model of Transient Cerebral Ischemia Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production Frequency and predictors of symptomatic intracranial hemorrhage after intravenous thrombolysis for acute ischemic stroke in a Brazilian public hospital.Evidence-based changes in devices and methods of endovascular recanalization therapy Inter-rater reliability of modified Alberta Stroke program early computerized tomography score in patients with brain infarction.Does preexisting antiplatelet treatment influence postthrombolysis intracranial hemorrhage in community-treated ischemic stroke patients? An observational study Initial 'TTP Map-Defect' of Computed Tomography Perfusion as a Predictor of Hemorrhagic Transformation of Acute Ischemic Stroke.Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post-Thrombolysis: Findings From Get With The Guidelines-Stroke.Advanced imaging improves prediction of hemorrhage after stroke thrombolysis.Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies.The Oxfordshire Community Stroke Project classification system predicts clinical outcomes following intravenous thrombolysis: a prospective cohort study.Safety and efficacy of alteplase in the treatment of acute ischemic stroke Glibenclamide for the treatment of acute CNS injury.Drug treatment of acute ischemic stroke.Use of intravenous recombinant tissue plasminogen activator in patients with borderline elevation of international normalized ratio.Accelerated dosing frequency of a pulmonary formulation of tissue plasminogen activator is well-tolerated in mice.Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke.Thrombosis, Neuroinflammation, and Poststroke Infection: The Multifaceted Role of Neutrophils in Stroke.Mechanical thrombectomy for the treatment of acute ischemic stroke.Hospital-based management of acute ischemic stroke following intravenous thrombolysis.Use of intravenous recombinant tissue plasminogen activator in patients outside the defined criteria: safety and feasibility issues.GLP-1R activation for the treatment of stroke: updating and future perspectives.tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.Cerebral Amyloid Angiopathy in Stroke Medicine.

P2860

Q24606564-82490753-9F1E-45B1-820E-A7DA739350E0 Q26772872-36FABA81-34F1-4A01-90D4-905546B5DA45 Q26796470-FA6262F4-E7CB-4653-83CB-4424536D976C Q26824338-807DCA1D-E2D9-4D36-BD87-162C0EAB8987 Q26830834-F4F6456E-39CC-42BC-89C3-9C0DB15CE3EF Q30380836-F150326A-206E-499A-B733-A31B5196A504 Q30620347-404EE417-E057-4888-99D5-ED3E5EAF01BC Q33560492-9D9B0DAB-CC0D-49EB-8555-E15342CCF537 Q33709160-204F660D-BB2E-45D6-8B82-4A6C6B2EB0EE Q33853254-20C2183F-1853-4FDD-88AF-2FE31CE4B7E7 Q33928297-E0BB832D-896D-4EC7-84D5-B71F8D954359 Q34018895-ABE98DBD-CB22-4278-B68E-8C39A1EF76EC Q34150522-07493701-777D-4C28-A6A7-8FAC7C6EC686 Q34777329-780A9F9A-E8DE-485E-B8B9-94535D1633DB Q35219628-21B26472-7516-40D7-8791-618CDA362B4A Q35649425-B84FF8A3-8851-432D-A1E8-BD36CF3117F6 Q35843660-7A85A6B7-3ED1-4847-9833-A29192EC3832 Q36010304-EAB6FF90-7CD2-4D3D-9711-3981E5E9AA2A Q36104057-E49AF892-7B18-4B98-BD41-ECD4C7E5CB11 Q36195764-3717103F-CDBD-4803-8B63-1DD02A4C1595 Q36196419-799E2340-A226-4ED8-A492-97C9B0AF1077 Q36620631-39654353-A3F2-4297-9E69-2B2061E1A659 Q36743950-B052A32D-8787-41AE-8C7D-E9F36B449271 Q36835905-4E29D880-BA6E-4027-9963-432A01E4563E Q36881065-F45340EF-8887-4BB3-B26B-28E1EECC6964 Q37052824-8AFCEEA9-3C71-4E9D-B800-BD5E467718CC Q37070899-2D7694E6-DDA1-4A55-9301-AD48AE2E617F Q37202149-CBCA5186-304F-41DB-904F-F483C964D704 Q37279993-2457B366-D4E7-4165-8C48-85F42F4F44C4 Q37342995-D3078DCD-BE6B-4147-A526-62C393DD8978 Q37403845-7153C1EF-0F5C-47A7-941A-E06998D20DD0 Q37426825-7236B663-970E-4ABE-8C9E-0861F6338BAD Q37674758-D2675A4A-C2FB-45B2-9F54-9D7CB28B8827 Q37694197-1C90D1C6-417F-4C70-B774-4F55DA838060 Q37732255-2C757770-D97A-4604-BCEE-65D71BF73A00 Q37868578-62FE598C-035B-40E1-9DA0-E99C9E73C079 Q38078028-34A41445-A679-4AB5-A735-0021D2045A5F Q38207948-BDA58839-B0D3-49EF-80B2-A8833A60D561 Q38965982-B6E29056-129C-4F2B-B027-1683714AF0D4 Q39126853-6A321E5A-A2A0-410E-8218-9F7F5442A890

P2860

Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors.

http://www.wikidata.org/entity/Q36829303

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Symptomatic intracerebral hemo ...... a review of the risk factors.

@en

type

label

Symptomatic intracerebral hemo ...... a review of the risk factors.

@en

prefLabel

Symptomatic intracerebral hemo ...... a review of the risk factors.

@en

P1433

Q36829303-1CAFCE5A-5DFB-4C60-9E94-391789150354

P1476

Q36829303-33A61C2F-FE7C-4AC6-949F-B532C9B15D9C

P2093

Q36829303-06AECAFD-1D53-46E0-9EC0-320804570D70

Q36829303-1053EECF-6C58-4F9A-A5CD-0DCC6AEB08A6

Q36829303-BA2DA27A-C5E8-4857-9C93-3A04E36B3699

P2860

Q36829303-02EA9965-A87C-464D-A407-49B19E8D5AC1

Q36829303-36439BD5-4D9A-4FB3-99AE-9E023F804BF1

Q36829303-3B0BBF5C-31A6-42AD-BD7A-6614607A2375

Q36829303-3EBE6D55-972C-4F4A-9946-3494F5A4E8DC

Q36829303-3F562B24-8C51-4520-9A52-2D18FDE32396

Q36829303-4584B6C7-686B-4E35-B399-26851641DAEA

Q36829303-589824A3-5893-44B2-B09F-6E7E57A71900

Q36829303-5D3F6997-48A4-40A3-B021-2EF89FE7D445

Q36829303-6A0B874E-B28C-4416-996F-8CD4011287D1

Q36829303-6CECD225-DEE7-4932-9F73-8D9B2235E1B8

P304

Q36829303-32BFC7B3-28EA-4CC8-A0B3-2C91B84D0855

P31

Q36829303-D949850B-7418-4B5D-85BE-DE04BC346FF0

P356

Q36829303-33D705F2-3AC5-4B48-9297-0D7B7FA81C47

P433

Q36829303-A599F3EC-F747-4D0F-83A8-A7B2350D650E

P478

Q36829303-C32E0D74-C003-43A5-9882-396509CA5F11

P577

Q36829303-5A99D1FF-E32F-47FA-8A6D-819CA60502A2

P698

Q36829303-F6AC65F4-372D-4E75-9667-E407AD247018

P921

Q36829303-1C53009F-8296-41CD-9531-3465164C7800

P356

P1433

Cerebrovascular Diseases

P1476

Symptomatic intracerebral hemo ...... a review of the risk factors.

@en

P2093

Christine A C Wijman

http://www.w3.org/2001/XMLSchema#string

Gregory W Albers

http://www.w3.org/2001/XMLSchema#string

Maarten G Lansberg

http://www.w3.org/2001/XMLSchema#string

P2860

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey

Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke

Metalloproteinases and their inhibitors in matrix remodeling

Tissue plasminogen activator for acute ischemic stroke

Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.

Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data.

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.

Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis.

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000103110

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17519538

http://www.w3.org/2001/XMLSchema#string

P921